A Portable Platform for Evaluation of Visual Performance in Glaucoma Patients.

Published online

Journal Article

PURPOSE: To propose a new tablet-enabled test for evaluation of visual performance in glaucoma, the PERformance CEntered Portable Test (PERCEPT), and to evaluate its ability to predict history of falls and motor vehicle crashes. DESIGN: Cross-sectional study. METHODS: The study involved 71 patients with glaucomatous visual field defects on standard automated perimetry (SAP) and 59 control subjects. The PERCEPT was based on the concept of increasing visual task difficulty to improve detection of central visual field losses in glaucoma patients. Subjects had to perform a foveal 8-alternative-forced-choice orientation discrimination task, while detecting a simultaneously presented peripheral stimulus within a limited presentation time. Subjects also underwent testing with the Useful Field of View (UFOV) divided attention test. The ability to predict history of motor vehicle crashes and falls was investigated by odds ratios and incident-rate ratios, respectively. RESULTS: When adjusted for age, only the PERCEPT processing speed parameter showed significantly larger values in glaucoma compared to controls (difference: 243ms; P<0.001). PERCEPT results had a stronger association with history of motor vehicle crashes and falls than UFOV. Each 1 standard deviation increase in PERCEPT processing speed was associated with an odds ratio of 2.69 (P = 0.003) for predicting history of motor vehicle crashes and with an incident-rate ratio of 1.95 (P = 0.003) for predicting history of falls. CONCLUSION: A portable platform for testing visual function was able to detect functional deficits in glaucoma, and its results were significantly associated with history of involvement in motor vehicle crashes and history of falls.

Full Text

Duke Authors

Cited Authors

  • Rosen, PN; Boer, ER; Gracitelli, CPB; Abe, RY; Diniz-Filho, A; Marvasti, AH; Medeiros, FA

Published Date

  • 2015

Published In

Volume / Issue

  • 10 / 10

Start / End Page

  • e0139426 -

PubMed ID

  • 26445501

Pubmed Central ID

  • 26445501

Electronic International Standard Serial Number (EISSN)

  • 1932-6203

Digital Object Identifier (DOI)

  • 10.1371/journal.pone.0139426

Language

  • eng

Conference Location

  • United States